LLY

1,101.9

-0.94%↓

JNJ

229

-0.8%↓

ABBV

218.76

-0.03%↓

UNH

404.37

-0.11%↓

NVS

148.01

-2.21%↓

LLY

1,101.9

-0.94%↓

JNJ

229

-0.8%↓

ABBV

218.76

-0.03%↓

UNH

404.37

-0.11%↓

NVS

148.01

-2.21%↓

LLY

1,101.9

-0.94%↓

JNJ

229

-0.8%↓

ABBV

218.76

-0.03%↓

UNH

404.37

-0.11%↓

NVS

148.01

-2.21%↓

LLY

1,101.9

-0.94%↓

JNJ

229

-0.8%↓

ABBV

218.76

-0.03%↓

UNH

404.37

-0.11%↓

NVS

148.01

-2.21%↓

LLY

1,101.9

-0.94%↓

JNJ

229

-0.8%↓

ABBV

218.76

-0.03%↓

UNH

404.37

-0.11%↓

NVS

148.01

-2.21%↓

Search

Check Cap Ltd

Atvērts

0

Pārskats

Akcijas cenas izmaiņa

24h

Šī brīža

Min

Max

Galvenie mērījumi

By Trading Economics

Ienākumi

-9.4K

EBITDA

-1.3M

Tirgus statistika

By TradingEconomics

Tirgus kapitalizācija

9.4M

Iepriekšējā atvēršanas cena

0

Iepriekšējā slēgšanas cena

0

Check Cap Ltd Grafiks

Pagātnes rezultāti nav uzticams nākotnes rezultātu rādītājs.

Par Check Cap Ltd

Check-Cap Ltd., a clinical stage medical diagnostics company, engages in the development of a capsule-based screening technology that utilizes ultra-low-dose X-rays to scan the inner lining of the colon for precancerous polyps, and other structural abnormalities in Israel. Its C-Scan system consists of C-Scan Cap, an X-ray scanning capsule for detection of suspected polyps; C-Scan Track, a disposable system attached to the patient's back through biocompatible adhesive skin patches; and C-Scan View software, a client/server-based application that enables procedure data download from the C-Scan Track, data analysis, and report generation. The company was incorporated in 2004 and is based in Isfiya, Israel.
help-icon Live chat